OVIDOvid Therapeutics Inc.
$2.34+40% 1Y
$2.34
$1.2052 weeks$2.96
The financials
Ovid Therapeutics Inc. by the numbers
Ovid Therapeutics Inc. (OVID) reported revenue of $733K in Q2 2026 (quarter ended Jun 30, 2026), down 88% from the same quarter a year earlier. That came with net loss of $15M. For the full year FY2025, revenue was $7.3M (+1181% year on year) and net income −$17M.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $733K | $6.3M | −88% |
| Operating income | −$16M | −$5.1M | n/a |
| Net income | −$15M | −$4.7M | n/a |